Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment-Reference-Cited by-同舟云学术

Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment

Published:2017-07-05 Issue:4 Volume:4 Page:660-664
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Callan Paul David¹,Baltabaeva Aigul¹,Kamal Mohammed¹,Wong Joyce¹,Lane Rebecca¹,Robertus Jan Lukas¹,Banner Nicholas R.¹

Affiliation:

1. Harefield Hospital; Hill End Road Harefield UB9 6JH UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12146/fullpdf

Reference13 articles.

1. Eosinophilic myocarditis: case series and review of literature;Ali;Can J Cardiol Vol,2006

2. Guidelines for diagnosis and treatment of myocarditis (JCS 2004);Japanese Circulation Society; Joint Working Group for Guidelines for Diagnosis and Treatment of Cardiovascular Diseases;J Cardiol,2005

3. Fulminant necrotizing eosinophilic myocarditis: a case report and comprehensive literature review;George;VAD J,2016

4. Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis;Morimoto;Heart Vessels,2003

5. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy;Maisch;Herz,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of acute myocarditis: a systematic review of clinical practice guidelines and recommendations;European Heart Journal - Quality of Care and Clinical Outcomes;2024-08-23

2. Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook;Journal of Clinical Medicine;2024-02-20

3. Reevaluation of Intravenous Steroid Therapy for Histologically Confirmed Myocarditis with Fulminant Presentation: Insights from the Japanese Registry of Fulminant Myocarditis;2023-09-14

4. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis;Circulation Journal;2023-04-25

5. Advances in Immunomodulatory Treatment for Fulminant Myocarditis in Children;Advances in Clinical Medicine;2023